本页面由Tiger Trade Technology Pte. Ltd.提供服务

再鼎医药

19.54
+0.24001.24%
盘后19.540.00000.00%19:58 EST
成交量:72.08万
成交额:1,400.97万
市值:21.69亿
市盈率:-12.19
高:19.73
开:19.18
低:19.02
收:19.30
52周最高:44.34
52周最低:15.96
股本:1.11亿
流通股本:1.09亿
量比:0.83
换手率:0.66%
股息:- -
股息率:- -
每股收益(TTM):-1.6026
每股收益(LYR):-1.6026
净资产收益率:-22.56%
总资产收益率:-12.16%
市净率:3.03
市盈率(LYR):-12.19

数据加载中...

2025/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/04/19

SEC问询函

Form CORRESP - Correspondence
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities